微环境TGF-β是NF1相关瘤形成的早期驱动因素
Alex Power1, Salome Stierli2, Elizabeth Harford-Wright1
1UCL Laboratory for Molecular Cell Biology and the UCL Cancer Institute, University College London, Gower Street, London WC1E 6BT, UK.
Cell reports
|January 14, 2026
概括
转化生长因子-β (TGF-β) 驱动神经纤维瘤在神经纤维瘤类型1 (NF1) 中的形成. 早期抑制TGF-β可以预防瘤的发展,为NF1患者提供潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 神经纤维素瘤类型1 (NF1) 是一种遗传性疾病,导致周围神经的瘤.
- 仅仅在施万细胞 (SCs) 中丧失NF1基因并不会导致瘤,但需要一个特定的微环境.
- 联系NF1损失,微环境和瘤形成的机制以前是未知的.
研究的目的:
- 鉴定NF1.1中神经纤维瘤形成所必需的微环境因素.
- 阐明转化生长因子-β (TGF-β) 在NF1瘤发生中的作用.
- 评估TGF-β抑制作为NF1.1的治疗策略.
主要方法:
- 在NF1小鼠模型中分析早期神经纤维瘤的形成.
- 研究Nf1缺乏的施万细胞与神经损伤微环境之间的相互作用.
- 在瘤发育的早期阶段对TGF-β的药理抑制.
主要成果:
- 转化生长因子-β (TGF-β) 被确定为神经纤维瘤发展的关键微环境信号.
- 缺少NF1的施万细胞在受伤后逃离再生神经,进入一个独特的促进瘤的微环境.
- TGF-β 破坏了施万细胞-轴突相互作用和SC重新分化,促进瘤发生.
- 早期的药理抑制TGF-β有效地预防了神经纤维瘤的形成.
结论:
- TGF-β是NF1中神经纤维瘤形成的关键驱动因素,通过改变施万细胞微环境.
- 在特定的早期治疗窗口中准TGF-β显示出预防NF1瘤的希望.
- TGF-β代表了治疗和预防神经纤维瘤在神经纤维瘤类型1形成的潜在治疗点.
关键词:
CP: 癌症 癌症 癌症科普:神经科学:神经科学是一门课.施万的细胞是斯万的细胞.在TGF-β的基础上.癌症 癌症 癌症 癌症 癌症巨细胞是什么?巨细胞是什么?微环境是一个微环境.神经损伤的神经损伤神经纤维瘤是一种神经纤维瘤.1型神经纤维素瘤病1型神经纤维素瘤神经元神经元的神经元周围神经系统 周围神经系统更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
14.2K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.1K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
